Heparin-Coated Intraocular Lens for Uveitis

Phase 2

Waitlist Available

Research Sponsored by National Eye Institute (NEI)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Women and men 18 years or older with a documented history of uveitis in an eye requiring cataract surgery

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is investigating the safety and efficacy of a heparin surface-modified intraocular lens in patients with uveitis undergoing cataract surgery.

Who is the study for?

This trial is for men and women over 18 with a history of uveitis who need cataract surgery. Their eye must have had no active inflammation for at least 3 months, even if they're on anti-inflammatory meds. People can't join if they only have one eye, can't commit to a year-long follow-up, or have corneal issues, uncontrolled glaucoma, or diabetes.Check my eligibility

What is being tested?

The study is testing the safety and effectiveness of a new heparin-coated intraocular lens in patients with severe uveitis undergoing cataract surgery. It aims to see how well this lens works and if it's safe to use in these specific conditions.See study design

What are the potential side effects?

While the side effects are not explicitly listed here, typical risks may include irritation or discomfort in the eye, infection risk post-surgery, potential vision changes or disturbances due to the lens implantation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older and need cataract surgery due to uveitis in my eye.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Eye Institute (NEI)Lead Sponsor

547 Previous Clinical Trials

1,402,157 Total Patients Enrolled

47 Trials studying Uveitis

18,174 Patients Enrolled for Uveitis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How does this remedy impact patient safety?

"This particular treatment has only been tested to a limited degree, thus our team at Power awarded it with an optimistic score of 2. This is partially based on the fact that this therapy has reached Phase 2 trials, meaning there are safety data but no efficacy data available yet."

Answered by AI

Are there available openings for participants in this clinical investigation?

"The details of this trial, which was originally listed on March 1st 1994 and updated lastly in June 23rd 2005, suggest that it is not recruiting new patients. However, 157 other trials are currently looking for participants to join their study."

Answered by AI